XENE
NASDAQ
$66.04
Xenon Pharmaceuticals Inc (XENE)
Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, is dedicated to developing therapies to treat patients with neurological disorders in Canada. The company is headquartered in Burnaby, Canada.
Sector:
Healthcare
Industry:
Biotechnology
Buy
Target: $80.56 (+21.99%)
Market Cap
$6.54B
EPS 5Y CAGR
+40.27%
FCF 5Y CAGR
+39.50%
Free Cash Flow Yield
-4.70%
Price Chart
Valuation
Market Cap$6.54B
P/S727.44
P/B4.89
Profitability
Gross Profit (TTM)-$328M
EBITDA-$410M
EPS-$4.65
Financial Health
Free Cash Flow Yield-4.70%
Growth & Risk
EPS 5Y CAGR+40.27%
FCF 5Y CAGR+39.50%
Beta (5Y)0.92
Sharpe Ratio1.39